'Podnosis': Catching up with the Fierce 15 of 2019 (part 2)
2024-02-07
Preview
来源: FierceHealthcare
None
This is the second part of our series reconnecting with Fierce 15 winners from 2019, the first year Fierce Healthcare published the list of 15 private companies engaged in pioneering work
This week on "Podnosis," we catch up with the leaders of Elemeno Health and Digital Diagnostics, both recognized as Fierce 15 winners in 2019.
First up, Fierce’s Anastassia Gliadkovskaya chats with Arup Roy-Burman, M.D., the founder and chief medical officer at Elemeno Health. Roy-Burman reflects on Elemeno’s evolving mission to democratize information and its entry into new markets, accelerated by the COVID-19 pandemic.
Next, Fierce’s Noah Tong catches us up with Digital Diagnostics. The Iowa-based company rose to prominence because of its AI system that enabled a specialist diagnosis for diabetic retinopathy in a primary care setting. Noah interviews CEO John Bertrand about the company’s global expansion, its approach toward value-based care and the future of AI.
To learn more about the topics in this episode:
Fierce Healthcare's Fierce 15 of 2019
Digital Diagnostics dials up $75M funding for diabetic retinopathy AI
Baxter taps Digital Diagnostics' diabetic retinopathy AI for its Welch Allyn eye scanners
Microsoft, Wolters Kluwer collaborate on 'big picture insights' analytics offering for hospitals
Privia Health joins forces with AI startup Navina for point-of-care clinical insights
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
靶点
-药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。